National Institute of Neurological Disorders and Stroke; Amended Notice of Meeting, 10539 [2014-03939]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 37 / Tuesday, February 25, 2014 / Notices
disorders and metabolic diseases
including dyslipidemia, diabetes and
atherosclerosis.
• Study of the role of FXR in
cholesterol biosynthesis and metabolic
disease.
Development Stage: Early-stage
Inventor: Frank J. Gonzalez (NCI)
Publications:
1. Sinal C, et al. Targeted disruption of the
nuclear receptor FXR/BAR impairs bile
acid and lipid homeostasis. Cell. 2000
Sep 15;102(6):731–44. [PMID 11030617]
2. Kim I, et al. Differential regulation of bile
acid homeostasis by the farnesoid X
receptor in liver and intestine. J Lipid
Res. 2007 Dec;48(12):2664–72. [PMID
17720959]
Intellectual Property: Research
Tools—Patent protection is not being
pursued for this technology:
• HHS Reference No. E–323–2001/
0—a mouse line lacking the nuclear
receptor FXR/BAR
• HHS Reference No. E–323–2001/
1—a mouse line lacking FXR/BAR
expression in the liver
• HHS Reference No. E–323–2001/
2—a mouse line lacking FXR/BAR
expression in the intestine
Licensing Contact: Tara L. Kirby,
Ph.D.; 301–435–4426; tarak@
mail.nih.gov
Musculoskeletal Rehabilitation Sciences
Overflow.
Date: February 28, 2014.
Time: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Jo Pelham, BA, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4102, MSC 7814, Bethesda, MD
20892, (301) 435–1786, pelhamj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 19, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–03941 Filed 2–24–14; 8:45 am]
BILLING CODE 4140–01–P
Dated: February 19, 2014.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2014–03957 Filed 2–24–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Amended Notice
of Meeting
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Notice is hereby given of a change in
the meeting of the National Institute of
Neurological Disorders and Stroke
Special Emphasis Panel, January 9,
2014, 09:00 a.m. to January 9, 2014,
01:00 p.m., National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 which
was published in the Federal Register
on February 13, 2014, 79FRN8727.
The meeting date has been changed to
March 7, 2014. The time and meeting
location remain the same. The meeting
is closed to the public.
Dated: February 19, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
emcdonald on DSK67QTVN1PROD with NOTICES
National Institutes of Health
[FR Doc. 2014–03939 Filed 2–24–14; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
VerDate Mar<15>2010
17:58 Feb 24, 2014
Jkt 232001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
10539
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases,
Special Emphasis Panel, Chronic Kidney
Disease (CKD) Biomarkers Consortium Data
Coordinating Center.
Date: March 18, 2014.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes Of Health,
Room 747, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Customized Stem
Cells for Clinical Application in Blood
Disorders (R24).
Date: March 25, 2014.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Paul A. Rushing, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes Of Health,
Room 747, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8895,
rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Cell and Molecular
Dynamics of Hematopoiesis in Vivo (R24).
Date: March 25, 2014.
Time: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 79, Number 37 (Tuesday, February 25, 2014)]
[Notices]
[Page 10539]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03939]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Neurological Disorders and Stroke Special Emphasis Panel,
January 9, 2014, 09:00 a.m. to January 9, 2014, 01:00 p.m., National
Institutes of Health, Neuroscience Center, 6001 Executive Boulevard,
Rockville, MD 20852 which was published in the Federal Register on
February 13, 2014, 79FRN8727.
The meeting date has been changed to March 7, 2014. The time and
meeting location remain the same. The meeting is closed to the public.
Dated: February 19, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-03939 Filed 2-24-14; 8:45 am]
BILLING CODE 4140-01-P
